Ciccarelli, Olga
Thompson, Alan
Article History
First Online: 29 January 2016
Competing interests
: A.T. has received honoraria and support for travel for consultancy from Biogen Idec, Eisai, Genzyme, Novartis and Medday, and for speaking from EXCEMED, Novartis, Remedica and Teva. He receives an honorarium from Sage Publications as Editor-in-Chief of <i>Multiple Sclerosis Journal</i>. O.C. serves as a consultant for Biogen, GE Healthcare and Novartis, and payments are made to the institution; she receives an honorarium as Associate Editor of <i>Neurology</i>.